Clinical Trial Update: Pharmacokinetic Study With an Oral Suspension of Perampanel as Adjunctive Therapy in Pediatric Subjects With Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetic study of an oral suspension of perampanel as adjunctive therapy in pediatric epilepsy subjects has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Perampanel (perampanel)

Snippet

Sponsor: Eisai Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2023-09-15